Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup
暂无分享,去创建一个
H. Goldschmidt | M. Dimopoulos | A. Palumbo | G. Gaidano | R. Hájek | A. Oriol | P. Moreau | W. Chng | H. Ludwig | T. Facon | L. Rosiñol | D. Joshua | K. Weisel | R. Niesvizky | L. Pour | T. Pika | H. Gillenwater | S. Feng | A. Suvorov | V. Goranova-Marinova | N. Mohamed | S. Aggarwal